Pharma Journalist 8962 posts 0 comments

Novartis announced an offer to acquire CellforCure from LFB. CellforCure, a French company, is one of the first and largest contract development and manufacturing organizations (CDMO)…
Read More...

Novartis announced that Susanne Schaffert, Ph.D., currently President, Advanced Accelerator Applications (AAA), a Novartis company, has been appointed CEO Novartis Oncology. She will…
Read More...

TOKYO & Astellas Pharma Inc. and Pfizer Inc. announced that the Phase 3 ARCHES trial evaluating XTANDI (enzalutamide) plus androgen deprivation therapy (ADT) in men with metastatic…
Read More...

AstraZeneca and Merck & Co., Inc., Kenilworth, N.J., US (Merck: known as MSD outside the US and Canada) announced positive results from the randomised, open-label, controlled, Phase…
Read More...

Mustang Bio announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to MB-102 (CD123 CAR T) for the treatment of blastic plasmacytoid dendritic…
Read More...

WuXi Biologics and AC Immune announced the first steps of an exclusive strategic collaboration that covers biologics discovery, development and manufacturing. AC Immune and WuXi…
Read More...

Ascentage Pharma announced that it has entered into a strategic collaboration with Genor Biopharma Co. Ltd. ("Genor"). As part of the agreement, the companies will explore the synergies…
Read More...

Sandoz, a Novartis division and the pioneer and global leader in biosimilars, announced that it has entered into an agreement to commercialize biosimilar versions of insulins used in…
Read More...

Pfizer Inc. and GlaxoSmithKline plc announced that they have entered into an agreement to create a premier global consumer healthcare company with robust iconic brands. The Boards of…
Read More...

Amgen and Molecular Partners AG announced a collaboration and license agreement for the clinical development and commercialization of MP0310 (FAP x 4-1BB). MP0310 is a preclinical…
Read More...